4//SEC Filing
Bhatia Kishor G. 4
Accession 0001493152-25-014615
CIK 0001763950other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 4:05 PM ET
Size
12.9 KB
Accession
0001493152-25-014615
Insider Transaction Report
Form 4
Bhatia Kishor G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-10-29+17,400→ 17,400 totalExercise: $5.04Exp: 2031-10-28→ Common Stock (17,400 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2020-06-15−52,200→ 0 totalExercise: $15.00Exp: 2030-06-14→ Common Stock (52,200 underlying) - Award
Stock Option (Right to Buy)
2020-06-15+52,200→ 52,200 totalExercise: $5.04Exp: 2030-06-14→ Common Stock (52,200 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2021-10-29−17,400→ 0 totalExercise: $10.21Exp: 2031-10-28→ Common Stock (17,400 underlying)
Footnotes (2)
- [F1]The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and one-third of the option vested 180 days from the grant date with the remaining two-thirds of the option vesting in equal monthly increments over the period commencing the 181st day after the grant date and ending 30 months thereafter (or 36 months after the grant date).
- [F2]The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on October 29, 2021 and provides for vesting in equal monthly increments over a 36-month period commencing November 29, 2021.
Documents
Issuer
Lantern Pharma Inc.
CIK 0001763950
Entity typeother
Related Parties
1- filerCIK 0001812638
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 4:05 PM ET
- Size
- 12.9 KB